CIK 0000784199 · Large accelerated filer
ARTIVION, INC.
Sign in to watch- Ticker
- AORT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 592417093
- Phone
- 7704193355
- Business address
- 1655 ROBERTS BOULEVARD N W, KENNESAW, GA, 30144
- Former names
- CRYOLIFE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,529,843
- in 3 filings
Net −$2,529,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-13 | Horton Amy VP, Chief Accounting Officer | Sale | −3,482 | $45.86 | $160K | 141,380 |
| 2025-11-13 | Davis John E Chief Commercial Officer | Sale | −6,563 | $45.86 | $301K | 198,842 |
| 2025-11-13 | Mackin James P President & CEO | Sale | −34,210 | $45.86 | $1.6M | 800,993 |
| 2025-11-13 | Holloway Jean F SVP, General Counsel | Sale | −5,761 | $45.86 | $264K | 163,408 |
| 2025-11-13 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −4,993 | $45.86 | $229K | 56,641 |
| 2025-11-11 | Holloway Jean F SVP, General Counsel | Option exercise | +10,000 | $11.03 | $110K | 179,169 |
| 2025-11-11 | Holloway Jean F SVP, General Counsel | Sale | −10,000 | $46.18 | $462K | 169,169 |
| 2025-11-11 | Holloway Jean F SVP, General Counsel | Option exercise · Stock Options (Right to buy) | −10,000 | 0 | ||
| 2025-11-10 | Holloway Jean F SVP, General Counsel | Sale | −2,960 | $44.62 | $132K | 169,169 |
| 2025-11-10 | Mackin James P President & CEO | Sale | −17,580 | $44.62 | $784K | 835,203 |
| 2025-11-10 | Davis John E Chief Commercial Officer | Sale | −3,373 | $44.62 | $150K | 205,405 |
| 2025-11-10 | Horton Amy VP, Chief Accounting Officer | Sale | −1,789 | $44.62 | $80K | 144,862 |
| 2025-11-10 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −2,566 | $44.62 | $114K | 61,634 |
| 2025-08-27 | Stanton Marshall S. SVP, Clinical & MD Affair | Option exercise | +18,200 | $11.03 | $201K | 82,400 |
| 2025-08-27 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | −18,200 | $44.02 | $801K | 64,200 |
| 2025-08-27 | Stanton Marshall S. SVP, Clinical & MD Affair | Option exercise · Stock Option (Right to Buy) | −18,200 | 0 | ||
| 2025-08-25 | Holloway Jean F SVP, General Counsel | Option exercise | +10,000 | $11.03 | $110K | 182,129 |
| 2025-08-25 | Holloway Jean F SVP, General Counsel | Sale | −10,000 | $44.37 | $444K | 172,129 |
| 2025-08-25 | Holloway Jean F SVP, General Counsel | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2025-08-15 | Mackin James P President & CEO | Sale | −12,500 | $42.32 | $529K | 852,783 |
Page 6 of 11 · 201 trades